A free pop-up exhibition and cultural hub featuring live programming and art from around the world, highlighting how drug policies impact and shape our communities.
The Thirty-ninth meeting of the Expert Committee on Drug Dependence (ECDD) will be held in Geneva, Switzerland, 6 – 10 November 2017.
At the meeting, the ECDD will review a number of psychoactive substances with potential for dependence, abuse and harm to health and make recommendations to the UN Secretary-General, on the need for and level of international control of these substances. The following substances will be reviewed:
1. Ocfentanil 2. Furanyl fentanyl (Fu-F) 3. Acryloylfentanyl (Acrylfentanyl) 4. Carfentanil 5. 4-fluoroisobutyrfentanyl (4-FIBF, pFIBF) 6. Tetrahydrofuranylfentanyl (THF-F) 7. 4-fluoroamphetamine (4-FA) 8. AB-PINACA 9. AB-CHMINACA 10. 5F-PB-22 11. UR-144 12. 5F-ADB 13. Etizolam 14. Pregabalin 15. Tramadol 16. Cannabidiol (CBD).
For more information, please do not hesitate to contact the Secretariat at: ecddsecretariat@who.int
Now in its fifth year and the third time hepatitis testing has been included, European HIV-Hepatitis Testing Week will take place from 17-24 November 2017.
The Association for Safer Drug Policies has invited some of the world’s leading voices in drug policy reform to share their harm prevention strategies.
Waterstones, 19-21 Tottenham Court Rd, London W1T 1BJ
27 November 2017
Join Tom Wainwright, author of 'Narconomics', in a panel discussion on Latin America’s drug war, its human and financial costs, and how this impacts other countries.